Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin + metformin fixed-dose combination versus metformin alone in type 2 diabetes
2008-001246-21Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Vildagliptin + metformin fixed-dose combination with Metformin monotherapy (2 arms). Primary endpoint: Change from baseline in HbA1c at Week 24. Started Aug 2008; status: completed.
02
Drugs
vildagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2008-001246-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001246-21.